phase readout
saveNCT05040217: A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment
ACTIVE_NOT_RECRUITINGupdated 2d ago
community read0 votes
Sponsor: Mark Tuszynski. Phase: PHASE1. Conditions: Alzheimer's Disease, Mild Cognitive Impairment
view source ↗
comments(0)
5-min edit window · permanent after that